New insight on the death toll of the COVID-19 pandemic worldwide has been published in the open-access eLife journal.
Comparing the impact of COVID-19 between countries or during a given period of time is challenging because reported numbers of cases and deaths can be affected by testing capacity and reporting policy. The current study provides a more accurate picture of the effects of COVID-19 than using these numbers, and may improve our understanding of this and future pandemics.
In any given period of time, a certain number of people die due to many particular reasons, such as old age, illness, violence, traffic accidents and more. Researchers are able to predict the number of deaths from these causes over coming months or years, known as expected deaths, using the same information gathered from previous months and years. However, pandemics, conflicts, and natural and man-made disasters cause additional deaths above and beyond those expected, which are known as ‘excess deaths’.
“Measuring excess deaths allows us to quantify, monitor and track pandemics such as COVID-19 in a way that goes above testing and reporting capacity and policy,” says Ariel Karlinsky, a graduate student at the Hebrew University of Jerusalem in Israel, and co-author alongside research scientist Dmitry Kobak, from Tübingen University, Germany. “However, until now, there has been no global, frequently updated repository of mortality data across countries.”
To fill this gap, Karlinsky and Kobak collected weekly, monthly or quarterly mortality data from 103 countries and territories, which they have made openly available as the World Mortality Dataset. They then used the data to work out the number of excess deaths in each country during the COVID-19 pandemic.
“We used our data to answer a number of questions,” Karlinsky explains. “Specifically, we wanted to find out whether the pandemic caused excess deaths in the countries we covered and, if so, to what extent. We were also curious to see whether the numbers of excess deaths were matched across countries.”
Their analyses showed that, in several of the countries worst affected by COVID-19 – namely Peru, Ecuador, Bolivia and Mexico – excess deaths were more than 50% above the expected annual mortality rate, or above 400 excess deaths per 100,000 people as in Peru, Bulgaria, North Macedonia and Serbia. At the same time, in countries such as Australia and New Zealand, mortality during the pandemic was below the usual level, which the authors suggest is likely due to social distancing measures reducing the number of deaths caused by other infections besides COVID-19.
Furthermore, the researchers found that while many countries have been reporting their COVID-19 death rates accurately, some including Nicaragua, Belarus, Egypt and Uzbekistan have underreported these numbers by more than 10 times.
“Together, our results present a comprehensive picture of the impact of COVID-19, which we hope will contribute to better understanding of the pandemic and assessing the success of different mitigation strategies,” Kobak concludes. “The work also highlights the importance of open and rapid mortality reporting for monitoring the effects of COVID-19. We hope that our dataset will provide a valuable resource to help other investigators answer their own questions about the pandemic. We are constantly expanding our dataset and will continue to track excess mortality around the world.”
Media contacts
Emily Packer
eLife
e.packer@elifesciences.org
+441223855373Tali Aronsky
The Hebrew University of Jerusalem
taliaron@savion.huji.ac.il
+972556664371
About
About eLife
eLife is a non-profit organisation created by funders and led by researchers. Our mission is to accelerate discovery by operating a platform for research communication that encourages and recognises the most responsible behaviours. We aim to publish work of the highest standards and importance in all areas of biology and medicine, including Epidemiology and Global Health, while exploring creative new ways to improve how research is assessed and published. eLife receives financial support and strategic guidance from the Howard Hughes Medical Institute, the Knut and Alice Wallenberg Foundation, the Max Planck Society and Wellcome. Learn more at https://elifesciences.org/about.
To read the latest Epidemiology and Global Health research published in eLife, visit https://elifesciences.org/subjects/epidemiology-global-health.
About Hebrew University
The Hebrew University of Jerusalem (HU) is Israel's leading academic and research institution, serving 24,000 students from 80 countries. Founded in 1918 by visionaries including Albert Einstein and Sigmund Freud, HU is ranked among the world's 100 leading universities. To date, HU faculty and alumni have won eight Nobel Prizes, one Fields Medal and one Abel Prize. For more information, visit http://new.huji.ac.il/en.
About the University of Tübingen
Innovative. Interdisciplinary. International. These have been our guiding principles in research and teaching since our founding in 1477. Tübingen’s success in the German government’s Excellence programs since 2012 have placed it among the most outstanding universities in Germany. The University is also well-placed in international higher education rankings.
More than 4,500 scientists and academics work at the University of Tübingen. We invest more than 200 million euros annually in a wide variety of research projects. As a comprehensive research university, Tübingen has solid foundations in the Sciences and Life Sciences as well as in the Humanities and Social Sciences. We have special strength due to our close collaboration with many non-university research institutions in our region and with notable universities around the world.
With more than 200 subjects on offer, the University of Tübingen gives prospective students a wide range of choices. A sharp focus on research is a major drawcard for Master’s students and doctoral candidates. The University not only trains our future experts and leaders; it is living up to its responsibility for the world of tomorrow.
